Steven Ratoff, a venture partner with ProQuest Investments, has been named interim president and CEO of NovaDel Pharma Inc. (AMEX: NVD), following the resignation of Jan Egberts. Ratoff has been on the NovaDel board since 2004, and chairman since 2006. The company said that it plans to initiate a search for a permanent replacement. www.novadel.com
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.